Search

everythinglearnresearchcommunity

for

Search:↓

A specific hair protein variant increases the spread of breast cancer and is linked to worse survival rates.

Testing for the NUDT 15 variant is crucial before starting azathioprine, especially in Asians.

Tenascin is present in normal skin and certain skin tumors but not in sebaceous glands or their tumors.

New signs like changes in blood markers, physical symptoms, and behavioral shifts may help detect hidden steroid use in athletes.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Targeting Keratin 17 may help overcome cancer therapy resistance.

Pulsed electric field treatment may help shrink untreated liver tumors.

Using LC-MS/MS for hormone measurement can prevent false high testosterone results and avoid unnecessary tests.

Breast cancer may be detectable through changes in scalp hair lipids.

Metastatic cervical cancer can cause rare, severe Cushing's syndrome with high risk of death.

Imaging helps detect adrenal gland issues and monitor treatment in congenital adrenal hyperplasia, and can identify tumors affecting fertility.

The document doesn't provide a clear conclusion or detailed findings about the impact of certain cells on cancer treatment.

A 90-year-old woman's hand lesion was a rare, aggressive skin cancer treated successfully with surgery.

Nurses are exposed to chemotherapy drugs, risking health issues like hair loss, so protective gear and monitoring are needed.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

T cell subsets are crucial in kidney cancer, and a new model predicts patient outcomes using key genes.

CD10 helps distinguish between basal cell carcinoma and benign hair follicle tumors.

Cytokeratin-15 loss is not specific to any single type of scarring alopecia.

Lower adrenal hormone levels may cause hair loss in postmenopausal women, certain patterns help diagnose nail cancer, and a gene variant linked to higher skin cancer risk in kidney transplant patients suggests monitoring folate levels.

The mTOR pathway may be involved in the development of hair follicle tumors, with higher activity in malignant tumors.

Colorectal cancer cells can adapt without losing their traits or drug sensitivity.

Low m6Ascores in melanoma predict better survival and response to immunotherapy.

Cutaneous angiosarcomas require a combined treatment approach, but prognosis is generally poor.

MRI helps distinguish between pituitary adenomas and craniopharyngiomas, guides treatment for pediatric CNS tumors, and assesses rhinocerebral mucormycosis with a high mortality rate in transplanted patients.

A patient with untreated congenital adrenal hyperplasia had large benign tumors in her adrenal glands removed, improving her symptoms.

SCUBE3 is a potential target for cancer and alopecia treatment but is challenging to target due to its varied roles.

Adrenocortical carcinoma is a rare, aggressive adrenal gland cancer with a poor outlook.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

DAB labeling effectively identifies collagen type III and PDGFR in horse skin, but may show false positives.